Rottenstein Law Group Skeptical But Hopeful About FDA Approval of First Ceramic-on-Metal Total Hip R

Rottenstein Law Group Skeptical But Hopeful About FDA Approval of First Ceramic-on-Metal Total Hip Replacement System The Rottenstein Law Group, which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by DePuy Orthopaedics, a subsidiary of Johnson & Johnson, is skeptical but hopeful that the first ceramic-on-metal total hip replacement system approved by the FDA will be free of the problems that plague metal-on-metal implant systems such as DePuy’s Pinnacle system. New York, NY (PRWEB) June 20, 2011 According to a June
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations